Biotech company developing next-generation antibiotics against multi-drug resistant bacteria. The company is advancing a complementary pipeline of small molecules against novel bacterial targets and with innovative modes of action to prevent resistance. Its lead program is an inhibitor of lipopolysaccharide synthesis in Gram-negative bacteria, and it also develops activators that trigger bacterial self-digestion.
Investment Rounds
Capital activity and funding progression
| Amount | Valuation | Date | Round | |
|---|---|---|---|---|
| €6.3 M | — | Jun, 2026 | unspecified | View |
Industries
Frequently Asked Questions
Where is Smartbax located?
Smartbax is located in Munich, Germany.
What industries does Smartbax operate in?
Smartbax operates in the following industries: biotech, antibiotics, drug discovery.
When was Smartbax founded?
Smartbax was founded on 2026-06-30.
How much total funding has Smartbax raised?
Smartbax has raised a total of $6,300,000.
Who are the investors in Smartbax?
The investors in Smartbax are: Frankfurt-based single family office, Anobis Asset, Bayern Kapital, Boehringer Ingelheim Venture Fund (BIVF).
What is the primary mission of Smartbax?
Smartbax is a Munich-based biotechnology company dedicated to developing a new generation of innovative small-molecule antibiotics to combat the rising threat of multi-drug-resistant bacteria and protect global health.
How does Smartbax approach the fight against antibiotic-resistant bacteria?
Unlike traditional antibiotics that typically inhibit essential bacterial processes, Smartbax focuses on novel mechanisms of action, such as the tailored activation of bacterial enzymes that trigger self-digestion in the bacteria, and targeting previously unexploited bacterial pathways.
Is Smartbax the same company as the gift experience brand Smartbox?
No, Smartbax is a distinct biotechnology company focused on antibiotic development and research. It is completely unrelated to the gift experience company known as Smartbox or the technology firm Smartbox.ai.
Is Smartbax a publicly traded company?
No, Smartbax is a private biotechnology company. It is supported by a consortium of investors, including venture capital funds and family offices.